Summit Therapeutics
SMMT
#1900
Rank
ยฃ7.87 B
Marketcap
ยฃ10.58
Share price
-5.97%
Change (1 day)
-39.51%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: ยฃ7.87 Billion

As of February 2026 Summit Therapeutics has a market cap of ยฃ7.87 Billion. This makes Summit Therapeutics the world's 1900th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ7.87 B-21.45%
2025ยฃ10.02 B-6.3%
2024ยฃ10.70 B645.31%
2023ยฃ1.43 B103.01%
2022ยฃ0.70 B263.19%
2021ยฃ0.19 B-31.35%
2020ยฃ0.28 B246.04%
2019ยฃ81.96 M449.9%
2018ยฃ14.9 M-87.82%
2017ยฃ0.12 B43.44%
2016ยฃ85.3 M-10.32%
2015ยฃ95.12 M

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Summit Therapeutics was reported to be:

ยฃ7.87 Billion
by Nasdaq info icon info icon
ยฃ7.87 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
ยฃ1.55 B-80.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
ยฃ0.16 B-97.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
ยฃ0.19 B-97.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
ยฃ4.50 B-42.81%๐Ÿ‡บ๐Ÿ‡ธ USA